Double-blind crossover study of once daily nifedipine coat core in essential hypertension.
CG Missouris, G A MacGregor(Charing Cross Hospital), Francesco P. Cappuccio(University Hospitals Coventry and Warwickshire NHS Trust), DRJ Singer(The University of Sydney), Nirmala D. Markandu(University of London)
PubMed
April 1, 1994
Cited by 1
Related Papers
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340